Product Information

AMIODARONE HCL 400 MG TABLET is a generic product labeled by Advagen Pharma Ltd., priced at $0.3938 per EA under NDC 72888006130. Its NADAC has been published 259 times since Sep 8, 2021.

FDA first approved this application on Nov 6, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMIODARONE HCL 400 MG TABLET

Amiodarone Hydrochloride
$0.3938per EA

Strength

400 mg/1

NDC

72888006130

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

AMIODARONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA078578

FDA Approved

11/6/2008

TE Code

AB

On Market Since

8/21/2020

Pharmacological Classes

Antiarrhythmic
Cytochrome P450 1A2 Inhibitors
Cytochrome P450 2C9 Inhibitors
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A Inhibitors
P-Glycoprotein Inhibitors

Price Statistics

The NADAC for AMIODARONE HCL 400 MG TABLET has been published 259 times since Sep 8, 2021, and over the history we have for it it has declined 77.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3938 per EA
All-time high$3.0563 (Apr 13, 2022)
All-time low$0.2214 (Aug 21, 2024)
52-week high$0.3938
52-week low$0.3410
Median price$0.7600
Average price$1.0335
Largest weekly change-74.0% (Mar 20, 2024)
Weeks tracked259
Tracking sinceSep 8, 2021

Price History

1W

+6.8%

1M

+6.8%

3M

+5.1%

6M

+11.4%

1Y

+2.9%

3Y

-65.5%

5Y

N/A

All

-77.1%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of AMIODARONE HCL 400 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for AMIODARONE HCL 400 MG TABLET, manufactured by Advagen Pharma Ltd., is $0.3938 per EA (NDC 72888006130), effective Aug 19, 2026.

How has the price of AMIODARONE HCL 400 MG TABLET changed over time?

Over the history we have for it, the NADAC for AMIODARONE HCL 400 MG TABLET has declined 77.1%. It has been tracked across 259 weekly CMS publications since Sep 8, 2021.

What are the highest and lowest recorded NADAC prices for AMIODARONE HCL 400 MG TABLET?

Since Sep 8, 2021, the NADAC for AMIODARONE HCL 400 MG TABLET has ranged from a low of $0.2214 (Aug 21, 2024) to a high of $3.0563 (Apr 13, 2022), with a median of $0.7600 per EA.

Are there cheaper alternatives to AMIODARONE HCL 400 MG TABLET?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMIODARONE HCL 400 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures AMIODARONE HCL 400 MG TABLET?

AMIODARONE HCL 400 MG TABLET (NDC 72888006130) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.